Advertisement
The scientific program will kick off with an opening plenary session,"Aerobiology, The Environment and Cardiovascular Health," on Monday, September22 at 8:10 a.m. Simultaneous sessions will include presentations by nationaland international heart failure experts, scientists, and allied health careprofessionals. Many will focus on the progressive treatments for heartfailure and the increased risk faced by patients.
Advertisement
"This year's conference will present exciting new information about thecauses and treatment of heart failure, and the important socio-economic issuessurrounding this condition," said Dr. Barry Greenberg, HFSA President, andProfessor of Medicine, Director, Heart Failure/Cardiac Transplantation Programat The University of California, San Diego School of Medicine.
Other scientific meeting sessions that address issues relating to heartfailure include:
-- Guideline updates on management of heart failure patients receivingcancer chemotherapy
-- Update on the genetic evaluation of heart failure
Late Breaking Clinical Trials to be presented that address issues relatingto heart failure include:
-- SADHART Trial: Safety and Efficacy of Sertraline for Depression inPatients with Chronic Heart Failure
-- PARTNERS HF: Multi-Site Program to Access and Review TrendingInformation and Evaluate Correlation to Symptoms in Patients with HeartFailure
For a complete list of annual meeting sessions or for details on attendingthe conference, call (617) 226-7198 or visit http://www.hfsa.org and click onAnnual Scientific Meeting. There is no registration fee for accreditedjournalists. Interview areas will be available on-site in addition to afully-staffed press room with phone and internet accessibility.
About Heart Failure
Heart failure is a progressive condition in which the heart muscle becomesweakened after it is injured from heart attack or high blood pressure andgradually loses its ability to pump enough blood to supply the body's needs.Many people are not aware they have heart failure because the symptoms areoften mistaken for signs of getting older. Heart failure affects from 4.6 to4.8 million individuals in the United States. Demographic and clinicalevidence strongly suggest the prevalence of heart failure will increasethroughout the next decade. Ten to 15 years ago heart failure was considered a"death sentence;" however, recent advances in treatment have shown that earlydiagnosis and proper care in early stages of the condition are key to slowing,stopping or in some cases reversing progression, improving quality of life,and extending life expectancy. For more information on heart failure, pleasevisit http://www.abouthf.org.
About the Heart Failure Society of America
The Heart Failure Society of America (HFSA) is a nonprofit educationalorganization, founded in 1994 as the first organized association of heartfailure experts. Today HFSA has over 1,700 members and provides a forum forall those interested in heart function, heart failure research and patientcare. The Society also serves as a resource for governmental agencies (FDA,NIH, NHLBI, CMS). The HFSA Annual Scientific Meeting is designed to highlightrecent advances in the development of strategies to address the complexepidemiological, clinical and therapeutic issues of heart failure. Additionalinformation on HFSA can be found at http://ww
